Literature DB >> 3539679

Gastric carcinoids and related endocrine growths.

E Solcia, C Capella, F Sessa, G Rindi, M Cornaggia, C Riva, L Villani.   

Abstract

A series of 30 gastric endocrine tumours has been revised in the light of available available cytologic and clinicopathologic information. Among 24 well differentiated endocrine tumours-16 with and 8 without chronic atrophic gastritis (CAG)-3 gastrin cell tumours have been distinguished from 21 argyrophil carcinoids, 15 of which showed light- and/or electronmicroscopy patterns of enterochromaffin-like (ECL) cell tumours, 2 of EC cell tumours and 1 of D1/P cell tumour. One case of mixed carcinoid/adenocarcinoma and 5 cases of endocrine carcinomas, 4 poorly and 1 moderately differentiated, were also identified. Achlorhydria, due to type A CAG or HCl-suppressing drugs, and bombesin hyperstimulation are among possible factors inducing G cell hyperfunction and/or hyperplasia. Hypergastrinaemia is among causative agents of argyrophil ECL cell hyperplasias and, possibly, of tumours of the oxynticopeptic mucosa, while chronic inflammation and gland atrophy with or without concomitant hypergastrinaemia are important factors in inducing both hyperplastic and tumour argyrophil growths in CAG mucosa.

Entities:  

Mesh:

Year:  1986        PMID: 3539679     DOI: 10.1159/000199378

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  33 in total

1.  Role of acetylcholine and gastrin-releasing peptide (GRP) in gastrin secretion.

Authors:  M Matsuno; T Matsui; A Iwasaki; Y Arakawa
Journal:  J Gastroenterol       Date:  1997-10       Impact factor: 7.527

2.  Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours.

Authors:  J K Ramage; A H G Davies; J Ardill; N Bax; M Caplin; A Grossman; R Hawkins; A M McNicol; N Reed; R Sutton; R Thakker; S Aylwin; D Breen; K Britton; K Buchanan; P Corrie; A Gillams; V Lewington; D McCance; K Meeran; A Watkinson
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

Review 3.  Unresolved surgical issues in the management of patients with Zollinger-Ellison syndrome.

Authors:  J A Norton; R T Jensen
Journal:  World J Surg       Date:  1991 Jan-Feb       Impact factor: 3.352

4.  Genetic differentiation of appendiceal tumor malignancy: a guide for the perplexed.

Authors:  Irvin M Modlin; Mark Kidd; Igor Latich; Michelle N Zikusoka; Geeta N Eick; Shrikant M Mane; Robert L Camp
Journal:  Ann Surg       Date:  2006-07       Impact factor: 12.969

5.  Quantitative electron microscopy of endocrine cells in oxyntic mucosa of normal human stomach.

Authors:  T D'Adda; A Bertelé; F P Pilato; C Bordi
Journal:  Cell Tissue Res       Date:  1989-01       Impact factor: 5.249

6.  Mucosal argyrophil endocrine cells in pernicious anaemia and upper gastrointestinal carcinoid tumours.

Authors:  S M Sjöblom; P Sipponen; S L Karonen; H J Järvinen
Journal:  J Clin Pathol       Date:  1989-04       Impact factor: 3.411

7.  Ultrastructural characterization of fundic endocrine cell hyperplasia associated with atrophic gastritis and hypergastrinaemia.

Authors:  C Bordi; C Ferrari; T D'Adda; F Pilato; G Carfagna; A Bertelé; G Missale
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

8.  Achlorhydria: hypergastrinaemia: carcinoids--a flawed hypothesis.

Authors:  C Bordi; W Creutzfeldt; R Håkanson; E Solcia; F Sundler
Journal:  Gut       Date:  1987-09       Impact factor: 23.059

9.  Guidance on the effective use of upper gastrointestinal histopathology.

Authors:  Maurice B Loughrey; Brian T Johnston
Journal:  Frontline Gastroenterol       Date:  2014-01-17

10.  Argyrophil cell hyperplasia and a carcinoid tumour in the stomach of a patient with sporadic Zollinger-Ellison syndrome.

Authors:  G E Feurle
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.